These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32475136)

  • 1. Do Benzodiazepines Cause Alzheimer's Disease?
    Salzman C
    Am J Psychiatry; 2020 Jun; 177(6):476-478. PubMed ID: 32475136
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials.
    Kishi T; Matsunaga S; Oya K; Ikuta T; Iwata N
    Int J Neuropsychopharmacol; 2015 Jun; 18(12):. PubMed ID: 26091818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.
    Gray SL; Dublin S; Yu O; Walker R; Anderson M; Hubbard RA; Crane PK; Larson EB
    BMJ; 2016 Feb; 352():i90. PubMed ID: 26837813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodromal Alzheimer's Disease Demonstrates Increased Errors at a Simple and Automated Anti-Saccade Task.
    Holden JG; Cosnard A; Laurens B; Asselineau J; Biotti D; Cubizolle S; Dupouy S; Formaglio M; Koric L; Seassau M; Tilikete C; Vighetto A; Tison F
    J Alzheimers Dis; 2018; 65(4):1209-1223. PubMed ID: 30149445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Benzodiazepine Use Associated With the Risk of Dementia and Cognitive Impairment-Not Dementia in Older Persons? The Canadian Study of Health and Aging.
    Nafti M; Sirois C; Kröger E; Carmichael PH; Laurin D
    Ann Pharmacother; 2020 Mar; 54(3):219-225. PubMed ID: 31595772
    [No Abstract]   [Full Text] [Related]  

  • 7. Benzodiazepine use and cognitive decline in the elderly.
    Picton JD; Marino AB; Nealy KL
    Am J Health Syst Pharm; 2018 Jan; 75(1):e6-e12. PubMed ID: 29273607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on "Do Benzodiazepines Cause Alzheimer's Disease?".
    Maust DT; Wiechers IR
    Am J Psychiatry; 2021 Feb; 178(2):205-206. PubMed ID: 33517758
    [No Abstract]   [Full Text] [Related]  

  • 9. Comment on "Do Benzodiazepines Cause Alzheimer's Disease?": Response to Maust and Wiechers.
    Salzman C
    Am J Psychiatry; 2021 Feb; 178(2):206. PubMed ID: 33517755
    [No Abstract]   [Full Text] [Related]  

  • 10. A clinical index to predict progression from mild cognitive impairment to dementia due to Alzheimer's disease.
    Lee SJ; Ritchie CS; Yaffe K; Stijacic Cenzer I; Barnes DE
    PLoS One; 2014; 9(12):e113535. PubMed ID: 25486250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selenium species in cerebrospinal fluid predicts conversion to Alzheimer's dementia in persons with mild cognitive impairment.
    Vinceti M; Chiari A; Eichmüller M; Rothman KJ; Filippini T; Malagoli C; Weuve J; Tondelli M; Zamboni G; Nichelli PF; Michalke B
    Alzheimers Res Ther; 2017 Dec; 9(1):100. PubMed ID: 29258624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuing education for the prevention of mild cognitive impairment and Alzheimer's-type dementia: a systematic review protocol.
    Matyas N; Auer S; Gisinger C; Kil M; Keser Aschenberger F; Klerings I; Gartlehner G
    Syst Rev; 2017 Aug; 6(1):157. PubMed ID: 28789697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cerebral microbleed prevalence relevant as a biomarker in amnestic mild cognitive impairment and mild Alzheimer's disease?
    Rabelo AG; Teixeira CV; Magalhães TN; Carletti-Cassani AFM; Amato Filho AC; Joaquim HP; Talib LL; Forlenza O; Ribeiro PA; Secolin R; Lopes-Cendes I; Cendes F; Balthazar ML
    Neuroradiol J; 2017 Oct; 30(5):477-485. PubMed ID: 28714354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.
    Garrett MD; Valle R
    Dementia (London); 2016 Mar; 15(2):239-54. PubMed ID: 24662500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief Cognitive Tests in the Case of Dementia and Alzheimer's Disease Early Diagnosis.
    Sagiadinou M; Plerou A
    Adv Exp Med Biol; 2020; 1195():127-135. PubMed ID: 32468467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Benzodiazepines in Alzheimer's Disease: A Systematic Review of Literature.
    Defrancesco M; Marksteiner J; Fleischhacker WW; Blasko I
    Int J Neuropsychopharmacol; 2015 May; 18(10):pyv055. PubMed ID: 25991652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green Tea Intake and Risks for Dementia, Alzheimer's Disease, Mild Cognitive Impairment, and Cognitive Impairment: A Systematic Review.
    Kakutani S; Watanabe H; Murayama N
    Nutrients; 2019 May; 11(5):. PubMed ID: 31137655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.